| abstract |
The compounds of the invention and pharmaceutically acceptable compositions thereof are useful as modulators of ATP-binding cassette ("ABC") transporters or fragments thereof, including cystic fibrosis transmembrane conductance regulator ("CFTR"). The invention also relates to methods of treating CFTR-mediated diseases using the compounds of the invention. |